Sharps Tech - STSS Net Assets per Single Share

Sharps Technology, Inc. (STSS) relies on a team of experienced engineers and FDA experts, minimizing employee turnover. Business efficiency is based on the implementation of secure injection systems and the optimization of costs for the mass production of syringes. The price action shown below is recorded at 4.55. Stability of supplies to clinics is ensured through an extensive pharmacy distribution network and specialized medical transportation.

To minimize risks during long-term investing, it is critical to assess net assets minus all liabilities, which reflects the actual equity per share. By analyzing the trend in book value per share, an investor can see how the capitalization of Sharps Technology, Inc. (STSS) innovations in safe medical systems transforms into fundamental stability and the intrinsic value of the business.